Literature DB >> 6610708

Direct effects of a monoclonal B cell differentiation factor and of purified interleukin 1 on B cell differentiation.

R J Falkoff, J L Butler, C A Dinarello, A S Fauci.   

Abstract

We have previously described the presence of factors in mixed lymphocyte culture supernatants that induce activated but not resting human B cells to secrete Ig. In the present study, we describe the effects of a B cell differentiation factor in the supernatant (SN) of a T-T hybridoma (clone 7D5). We find that it induces Ig secretion by human B cells in the absence of T cells or monocytes. It acts only on activated B cells, because small (resting) B cells isolated by centrifugal counterflow elutriation do not respond to it, whereas the same cells do develop into Ig-secreting cells if activated in culture with Staphylococcus aureus Cowan I before exposure to SN 7D5. By using class-specific reagents in enzyme-linked immunosorbent assays, we found SN 7D5 to result in the secretion of significant amounts of IgM, IgG, and IgA. We also studied the effects of highly purified interleukin 1 on this differentiation process. Interleukin 1 by itself failed to induce Ig secretion by activated B cells, and its presence was not required for the induction of Ig secretion by SN 7D5. However, interleukin 1 consistently synergized with SN 7D5 in inducing Ig secretion by purified B cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6610708

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Differentiation of human B lymphocyte subpopulations induced by an alloreactive helper T-cell clone.

Authors:  S J Anderson; D S Hummell; A R Lawton
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

2.  Effect of tumor necrosis factor alpha on mitogen-activated human B cells.

Authors:  J H Kehrl; A Miller; A S Fauci
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

3.  Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.

Authors:  T Defrance; J P Aubry; F Rousset; B Vanbervliet; J Y Bonnefoy; N Arai; Y Takebe; T Yokota; F Lee; K Arai
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

4.  Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.

Authors:  C N Baxevanis; G V Dedoussis; A D Gritzapis; G P Stathopoulos; M Papamichail
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.